Genmab — Oktober 2018

[royal]

Hvis Nasdaq for mistanke om en lovovertrædelse, er de forpligtigede til at anmelde det til den relevante nationale kompetente myndighed, hvilket i Danmark er Finanstilsynet. Det behøver dog ikke ske i realtid, men når Nasdaq har haft mulighed for nærmere at afdække de relevante forhold i sagen.
Med venlig hilsen
Brian Mikkelsen

[JKY_VH]

Ser ud til, at kvindemennesket fra HSBC og OHW er de nye "stjerneanalytikere" i Genmab. Verden er af lave.

[bibob]

[Legolas23]

Måske den samme.

[JKY_VH]

[jkj]

Godmorgen

[bibob]

God morgen.

[transalp]

Go morgen

[polle1]

God morgen og god dag

[E_L]

There will also be data for …… and ofatumumab (OMB157), https://www.nasdaq.com/article/novartis-to-present-33-scientific-abstracts-20181010-00038

[E_L]

this seems just on study design https://onlinelibrary.ectrims-congress.eu/ectrims/2018/ectrims-2018/228807/ludwig.kappos.ofatumumab.versus.teriflunomide.in.relapsing.multiple.sclerosis.html?f=media=3*search=ofatumumab*listing=3*browseby=8

[Solsen]

Sounds exciting with the first self- administered subcutaneous B-cell therapy

[OHW]

JKY, gør ikke nar af eller skyd budbringeren. Jeg oplyser bare, hvilke scenarier der KAN udspille sig baseret på min erfaring med marked og TA.

[E_L]

yes @Solsen ,
a bit surprised they already come out with that statement, the study isn't even recruiting yet? https://clinicaltrials.gov/ct2/show/NCT03560739 Or has it been in the clinic before?

[Solsen]

Not to my knowledge.

[Helge_LarsenPI-redaktør]

TA versus FA: http://www.proinvestor.com/debat/76350

[gentogen]

ClinicalTrials.gov

(clinicaltrials.gov)

[Bulder]

I think ofa will be self-administered what ever they choose prefilled syringes or autoinjectors. https://www.sciencedirect.com/topics/medicine-and-dentistry/autoinjector

[E_L]

yes, i expect that too, and they seem optimistic about their new injection toy in that statement. I am not sure they used it already in that study @gentogen

[E_L]

the injection tool i mean